0000950170-23-033420.txt : 20230718
0000950170-23-033420.hdr.sgml : 20230718
20230718180456
ACCESSION NUMBER: 0000950170-23-033420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230718
DATE AS OF CHANGE: 20230718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAPORTE KATHLEEN
CENTRAL INDEX KEY: 0001196201
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 231095208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 432-9270
MAIL ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
ownership.xml
4
X0508
4
2023-07-17
0001785173
89bio, Inc.
ETNB
0001196201
LAPORTE KATHLEEN
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
true
false
false
false
false
Common Stock
2023-07-17
4
M
false
12500
2.64
A
12500
D
Common Stock
2023-07-17
4
S
false
12500
18.80
D
0
D
Stock Option (Right to Buy)
2.64
2023-07-17
4
M
false
12500
0
D
2032-05-16
Common Stock
12500
12500
D
This transaction was executed in multiple trades at prices ranging from $18.77 to $18.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This option is vested in full.
/s/ Ryan A. Murr, as attorney-in-fact for Kathleen LaPorte
2023-07-18